The pharmaceutical solvent N-methyl-2-pyrollidone (NMP) attenuates inflammation through Krüppel-like factor 2 activation to reduce atherogenesis

por Roche-Molina, Marta, Hardwick, Bryn, Sanchez-Ramos, Cristina, Sanz-Rosa, David, Gewert, Dirk, Cruz, Francisco M., Gonzalez-Guerra, Andres, Andres, Vicente, Palma, Joaquin A., Ibanez, Borja, Mckenzie, Grahame, Bernal, Juan A.
Publicado 2020